There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...

Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer’s disease, formed by the accumulation of tau protein into ...

Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...

Gut alterations in Alzheimer’s disease can be identified using nano- and micro-XPCT, offering a new method for early disease ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

Using a powerful X-ray imaging technique, they have found detailed structural changes in the intestines of mice with ...

University of Queensland researchers have discovered that nearly 70% of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors that ...